For the twelve months ended Jul 4, 2026, Aveanna Healthcare Holdings Inc. reported $2.60B of revenue and $274.76M of net income.
AVAH revenue was $670.48M in fiscal Q2 2026 (ended Jul 4, 2026), up 13.7% from a year earlier and up 3.5% from the prior quarter. For the full fiscal 2025 it was $2.43B, up 20.2% from fiscal 2024. Compound annual growth was +10.2% over 5 years. It rose in each of the last 6 fiscal years. Fiscal 2025 is the highest of the 7 fiscal years on file.
AVAH net income was $40.29M in fiscal Q2 2026 (ended Jul 4, 2026), up 49.1% from a year earlier and down 3.3% from the prior quarter. For the full fiscal 2025 it was $225.03M, compared with -$10.93M in fiscal 2024. Fiscal 2025 is the highest of the 7 fiscal years on file.
AVAH diluted EPS was $0.18 in fiscal Q2 2026 (ended Jul 4, 2026), up 38.5% from a year earlier and down 5.3% from the prior quarter. For the full fiscal 2025 it was $1.05, compared with -$0.06 in fiscal 2024.
| Line item | Jan 3, 2026 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 | Jan 2, 2021 | Dec 28, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.43B | $2.02B | $1.90B | $1.79B | $1.68B | $1.50B | $1.38B |
| Gross profit | $810.48M | $635.54M | $595.43M | $553.23M | $542.40M | $454.51M | $419.25M |
| Selling, general and admin | $374.50M | $352.81M | $360.98M | $357.23M | $297.38M | $240.95M | $227.76M |
| Operating income | $256.46M | $139.79M | $8.07M | -$642.28M | -$36.11M | -$3.49M | $38.95M |
| Interest expense | $140.09M | $156.60M | $153.25M | $107.72M | $68.93M | $82.98M | $92.30M |
| Pre-tax income | $106.95M | $5.07M | -$139.00M | -$663.81M | -$113.58M | -$51.73M | -$75.03M |
| Income tax | -$118.09M | $16.00M | -$4.47M | -$1.78M | $3.47M | $5.32M | $1.49M |
| Net income | $225.03M | -$10.93M | -$134.52M | -$662.03M | -$117.04M | -$57.05M | -$76.52M |
| EPS, basic | $1.11 | -$0.06 | -$0.71 | -$3.57 | -$0.69 | -$0.40 | -$0.56 |
| EPS, diluted | $1.05 | -$0.06 | -$0.71 | -$3.57 | -$0.69 | -$0.40 | -$0.56 |
| Diluted shares | 215.0M | 192.9M | 190.0M | 185.6M | 170,625 | 141.0M | 136.9M |
| Line item | Jan 3, 2026 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 | Jan 2, 2021 | Dec 28, 2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $193.26M | $84.29M | $43.94M | $19.22M | $30.49M | $137.34M | - |
| Receivables | $313.36M | $265.19M | $236.56M | $221.24M | $218.92M | $172.89M | - |
| Current assets | $560.23M | $392.67M | $314.89M | $269.75M | $279.21M | $340.64M | - |
| Goodwill | $1.12B | $1.05B | $1.05B | $1.16B | $1.84B | $1.32B | $1.23B |
| Total assets | $2.01B | $1.66B | $1.61B | $1.71B | $2.33B | $1.84B | - |
| Current liabilities | $424.46M | $402.17M | $354.76M | $326.50M | $344.83M | $260.41M | - |
| Short-term debt | $13.25M | $9.20M | $9.20M | $9.20M | $8.60M | $9.91M | - |
| Long-term debt | $1.29B | $1.27B | $1.28B | $1.28B | $1.23B | $1.16B | - |
| Total debt | $1.30B | $1.28B | $1.29B | $1.29B | $1.24B | $1.17B | - |
| Total liabilities | $1.82B | $1.79B | $1.74B | $1.72B | $1.70B | $1.58B | - |
| Shareholders' equity | $194.46M | -$123.55M | -$129.57M | -$6.31M | $635.82M | $265.03M | $270.19M |
| Line item | Jan 3, 2026 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 | Jan 2, 2021 | Dec 28, 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $125.86M | $32.64M | $22.67M | -$48.40M | -$11.35M | $116.62M | -$8.71M |
| Capital expenditures | - | - | - | - | $15.95M | $15.24M | $16.64M |
| Free cash flow | - | - | - | - | -$27.30M | $101.38M | -$25.35M |
| Investing cash flow | -$22.30M | -$6.32M | -$8.79M | -$25.29M | -$681.83M | -$193.54M | -$17.82M |
| Financing cash flow | $5.41M | $14.03M | $10.85M | $62.42M | $586.33M | $210.94M | $21.86M |
| Stock-based compensation | $25.06M | $17.46M | $13.16M | $15.89M | $14.43M | $3.27M | $1.95M |
| Depreciation and amortization | $10.54M | $10.78M | $13.78M | $21.31M | $20.55M | $17.03M | $14.32M |
| Line item | Jan 3, 2026 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 | Jan 2, 2021 | Dec 28, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 20.2% | 6.8% | 6.0% | 6.5% | 12.3% | 8.0% | - |
| Gross margin | 33.3% | 31.4% | 31.4% | 30.9% | 32.3% | 30.4% | 30.3% |
| Operating margin | 10.5% | 6.9% | 0.4% | -35.9% | -2.2% | -0.2% | 2.8% |
| Net margin | 9.2% | -0.5% | -7.1% | -37.0% | -7.0% | -3.8% | -5.5% |
| Free cash flow margin | - | - | - | - | -1.6% | 6.8% | -1.8% |
| Return on equity | 115.7% | - | - | - | -18.4% | -21.5% | -28.3% |
| Return on assets | 11.2% | -0.7% | -8.3% | -38.7% | -5.0% | -3.1% | - |
| Current ratio | 1.32 | 0.98 | 0.89 | 0.83 | 0.81 | 1.31 | - |
| Debt to equity | 6.68 | - | - | - | 1.94 | 4.43 | - |
| Line item | Jul 4, 2026 | Apr 4, 2026 | Jan 3, 2026 | Sep 27, 2025 | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $670.48M | $647.91M | $662.48M | $621.94M | $589.55M | $559.22M | $519.87M | $509.02M | $504.96M | $490.65M | $478.84M | $478.01M |
| Gross profit | $218.53M | $205.43M | $213.30M | $202.82M | $210.80M | $183.56M | $171.72M | $159.70M | $158.27M | $145.85M | $148.45M | $147.26M |
| Selling, general and admin | $97.08M | $95.79M | $97.64M | $95.40M | $90.07M | $91.39M | $88.74M | $88.18M | $87.97M | $87.91M | $87.01M | $91.00M |
| Operating income | $79.98M | $69.33M | $71.05M | $53.58M | $80.03M | $51.80M | $45.77M | $34.02M | $37.13M | $22.87M | $29.29M | -$76.35M |
| Interest expense | $27.78M | $29.16M | $32.62M | $35.13M | $36.00M | $36.34M | $38.10M | $39.24M | $39.61M | $39.65M | $39.70M | $39.60M |
| Pre-tax income | $56.47M | $44.98M | $39.24M | $13.42M | $44.14M | $10.15M | $26.93M | -$27.33M | $3.98M | $1.49M | -$31.59M | -$101.76M |
| Income tax | $16.18M | $3.32M | -$139.51M | -$647.0K | $17.11M | $4.96M | -$2.25M | $15.51M | -$9.93M | $12.66M | -$5.86M | $631.0K |
| Net income | $40.29M | $41.65M | $178.75M | $14.06M | $27.02M | $5.19M | $29.18M | -$42.84M | $13.91M | -$11.17M | -$25.74M | -$102.39M |
| EPS, basic | $0.19 | $0.19 | $0.88 | $0.07 | $0.13 | $0.03 | $0.15 | -$0.22 | $0.07 | -$0.06 | -$0.14 | -$0.54 |
| EPS, diluted | $0.18 | $0.19 | $0.83 | $0.06 | $0.13 | $0.03 | $0.15 | -$0.22 | $0.07 | -$0.06 | -$0.13 | -$0.54 |
| Diluted shares | 224.9M | 222.1M | - | 222.2M | 210.4M | 206.2M | - | 193.4M | 196.9M | 192.2M | - | 189.1M |
| Line item | Jul 4, 2026 | Apr 4, 2026 | Jan 3, 2026 | Sep 27, 2025 | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $97.20M | $189.27M | $193.26M | $145.87M | $100.74M | $71.49M | $84.29M | $78.46M | $47.66M | $42.61M | $43.94M | $48.29M |
| Receivables | $337.23M | $332.69M | $313.36M | $312.83M | $316.28M | $294.83M | $265.19M | $265.45M | $272.96M | $257.54M | $236.56M | $235.67M |
| Current assets | $478.09M | $575.30M | $560.23M | $502.60M | $449.92M | $407.62M | $392.67M | $381.37M | $364.00M | $336.04M | $314.89M | $318.25M |
| Goodwill | $1.28B | $1.12B | $1.12B | $1.12B | $1.12B | $1.05B | $1.05B | $1.05B | $1.05B | $1.05B | $1.05B | $1.05B |
| Total assets | $2.11B | $2.02B | $2.01B | $1.81B | $1.77B | $1.66B | $1.66B | $1.64B | $1.66B | $1.64B | $1.61B | $1.65B |
| Current liabilities | $411.32M | $390.43M | $424.46M | $409.69M | $414.23M | $388.31M | $402.17M | $406.04M | $389.15M | $381.93M | $354.76M | $364.30M |
| Short-term debt | $13.25M | $13.25M | $13.25M | $13.25M | $9.20M | $9.20M | $9.20M | $9.20M | $9.20M | $9.20M | $9.20M | $9.20M |
| Long-term debt | $1.28B | $1.28B | $1.29B | $1.29B | $1.27B | $1.27B | $1.27B | $1.28B | $1.27B | $1.28B | $1.28B | $1.28B |
| Total debt | $1.30B | $1.30B | $1.30B | $1.30B | $1.28B | $1.28B | $1.28B | $1.28B | $1.28B | $1.28B | $1.29B | $1.29B |
| Total liabilities | $1.82B | $1.78B | $1.82B | $1.80B | $1.78B | $1.76B | $1.79B | $1.80B | $1.78B | $1.78B | $1.74B | $1.76B |
| Shareholders' equity | $287.28M | $240.05M | $194.46M | $9.18M | -$11.99M | -$100.13M | -$123.55M | -$156.44M | -$118.97M | -$136.27M | -$129.57M | -$105.71M |
| Line item | Jul 4, 2026 | Apr 4, 2026 | Jan 3, 2026 | Sep 27, 2025 | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $80.93M | $4.35M | $49.72M | $33.20M | $51.57M | -$8.63M | $13.41M | $29.39M | $1.81M | -$11.97M | -$3.00M | $28.70M |
| Investing cash flow | -$175.37M | -$4.56M | -$1.95M | -$2.02M | -$15.98M | -$2.35M | -$1.53M | -$2.21M | -$1.27M | -$1.31M | -$1.57M | -$1.13M |
| Financing cash flow | $2.36M | -$3.78M | -$377.0K | $13.95M | -$6.34M | -$1.81M | -$6.05M | $3.62M | $4.51M | $11.95M | $221.0K | -$7.29M |
| Stock-based compensation | $4.13M | $4.15M | $3.95M | $4.96M | $5.16M | $11.00M | $4.98M | $4.90M | $3.50M | $4.08M | $3.01M | $5.12M |
| Depreciation and amortization | $2.85M | $3.04M | $2.73M | $2.60M | $2.62M | $2.59M | $2.45M | $2.59M | $2.83M | $2.91M | $3.28M | $2.96M |
| Line item | Jul 4, 2026 | Apr 4, 2026 | Jan 3, 2026 | Sep 27, 2025 | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 13.7% | 15.9% | 27.4% | 22.2% | 16.8% | 14.0% | 8.6% | 6.5% | 7.0% | 5.2% | 6.1% | 7.9% |
| Net income growth, YoY | 49.1% | 702.1% | 512.6% | - | 94.3% | - | - | - | -45.7% | - | - | - |
| EPS growth, YoY | 38.5% | 533.3% | 453.3% | - | 85.7% | - | - | - | -46.2% | - | - | - |
| Gross margin | 32.6% | 31.7% | 32.2% | 32.6% | 35.8% | 32.8% | 33.0% | 31.4% | 31.3% | 29.7% | 31.0% | 30.8% |
| Operating margin | 11.9% | 10.7% | 10.7% | 8.6% | 13.6% | 9.3% | 8.8% | 6.7% | 7.4% | 4.7% | 6.1% | -16.0% |
| Net margin | 6.0% | 6.4% | 27.0% | 2.3% | 4.6% | 0.9% | 5.6% | -8.4% | 2.8% | -2.3% | -5.4% | -21.4% |
| Current ratio | 1.16 | 1.47 | 1.32 | 1.23 | 1.09 | 1.05 | 0.98 | 0.94 | 0.94 | 0.88 | 0.89 | 0.87 |
| Debt to equity | 4.52 | 5.40 | 6.68 | 141.83 | - | - | - | - | - | - | - | - |
Source: XBRL data Aveanna Healthcare Holdings Inc. files with the SEC, latest filing dated Aug 13, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| AVAH | $2.60B | +19.5% | $274.76M | 10.6% | $2.98B |
| BTSG | $15.25B | +26.0% | $410.27M | 2.7% | $13.11B |
| CHE | $2.66B | +5.2% | $282.40M | 10.6% | $6.95B |
| HIMS | $2.58B | +28.0% | -$142.03M | -5.5% | $5.61B |
| LFST | $1.68B | +22.6% | $71.91M | 4.3% | $5.13B |
| OPCH | $5.75B | +4.0% | $215.19M | 3.7% | $4.72B |
| PRVA | $2.43B | +19.2% | $36.08M | 1.5% | $3.06B |
| ADUS | $1.50B | +11.5% | $111.05M | 7.4% | $2.37B |
| WGS | $454.43M | +25.4% | -$106.36M | -23.4% | $1.92B |